Evidence map›Paper›PMID 42096278›Full record

ReviewRevista medica del Instituto Mexicano del Seguro Social2026

[Sinonasal ameloblastoma: Clinical case presentation and literature review].

Francisco Javier Martínez-Fernández, Fany Gabriela Juárez-Aguilar

Abstract readCase ReportsEnglish AbstractReview
In one paragraph

Review in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francisco Javier Martínez-FernándezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Anatomía Patológica. Ciudad de México, México.ORCID 0009-0008-9657-539X
Fany Gabriela Juárez-AguilarInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Anatomía Patológica. Ciudad de México, México.ORCID 0000-0002-6204-3677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sinonasal ameloblastoma is considered a locally benign, rare, and locally aggressive neoplasm. It is included within the so-called peripheral ameloblastomas. The symptoms are nonspecific, such as epistaxis, rhinorrhea, and nasal obstruction. The diagnosis requires a broad approach, imaging studies and complete clinical history; however, the histopathological diagnosis is the gold standard. As for treatment, the mainstay is surgical; however, it is currently being studied to complement it with radiotherapy or BRAF inhibitors. The objective was to present a clinical case of a Mexican patient, as well as to make a bibliographic review of the subject. Clinical case: Woman originally from and resident of Mexico City who began with hearing loss, rhinorrhea, and nasal obstruction. Imaging studies revealed a mass that completely occupied the right maxillary sinus and the ipsilateral nasal cavity. The pathology study revealed that it was an ameloblastoma. Conclusions: Although rare, the described case presented the clinical characteristics described in the international literature, and even though there are no standardized guidelines for the treatment of this entity, appropriate treatment was provided in accordance with international recommendations for these cases.

Indexed as

AmeloblastomaMaxillary Sinus NeoplasmsFemaleHumansAmeloblastomaHead and Neck NeoplasmsNasal PolypNeoplasia OdontogénicaNeoplasias de Cabeza y CuelloOdontogenic NeoplasmPólipo Nasal

Identifiers

PMID42096278
PMCPMC13196994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.